| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |